ASP
SRRA

Adams Street Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Adams Street Partners’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,461
Closed -$1.47M – 22
2016
Q2 		$1.47M Sell
18,461
-9,582
-34% -$1.83M 0.24% 10
2016
Q1 		$7.56M Sell
28,043
-946
-3% -$302K 1.38% 8
2015
Q4 		$15.7M Hold
28,989
– – 2.82% 6
2015
Q3 		$17.8M Buy
+28,989
New +$32.7M 3.79% 5

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Adams Street Partners's SRRA Position: Q3 2016 in Review

Adams Street Partners sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2016, closing a stake of 18,461 shares — an estimated $1.47M sold.

Adams Street Partners first reported a position in SRRA in Q3 2015 and held it in 4 quarters. The position peaked at $17.8M in Q3 2015. 42 funds tracked by Wall St. Rank hold SRRA as of Q3 2016.

  • Adams Street Partners reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Adams Street Partners sold 18,461 Sierra Oncology, Inc. Common Stock shares in Q3 2016, an estimated $1.47M.
  • Adams Street Partners first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Adams Street Partners's Sierra Oncology, Inc. Common Stock position peaked at $17.8M in Q3 2015.
  • 42 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2016.

Based on Adams Street Partners's 13F filing for Q3 2016, filed 14 Nov 2016.